GOLDMAN SACHS GROUP INC - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 59 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$9,607,647
+1918.4%
642,652
+1010.6%
0.00%
Q3 2022$476,000
+244.9%
57,864
+174.7%
0.00%
Q2 2022$138,000
+62.4%
21,067
+38.8%
0.00%
Q1 2022$85,000
-93.0%
15,178
-94.1%
0.00%
Q4 2021$1,211,000
-30.4%
258,108
-8.4%
0.00%
Q3 2021$1,741,000
-23.0%
281,667
-17.8%
0.00%
-100.0%
Q2 2021$2,260,000
+608.5%
342,842
+686.3%
0.00%
Q1 2021$319,000
+31.3%
43,603
+3.6%
0.00%
Q4 2020$243,000
-63.3%
42,080
-62.3%
0.00%
Q3 2020$663,000
+77.3%
111,607
+53.8%
0.00%
Q2 2020$374,00072,5690.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,952,958$23,481,0000.99%
Cormorant Asset Management, LP 1,000,000$5,940,0000.23%
WealthTrust Axiom LLC 22,347$132,0000.06%
SECTORAL ASSET MANAGEMENT INC 100,000$594,0000.05%
Virtu Financial LLC 24,577$146,0000.02%
PDT Partners, LLC 61,839$367,0000.02%
SABBY MANAGEMENT, LLC 26,039$155,0000.02%
MGO ONE SEVEN LLC 10,000$59,0000.01%
WINTON GROUP Ltd 45,208$269,0000.01%
Ancora Advisors LLC 36,350$216,0000.01%
View complete list of AVEO PHARMACEUTICALS INC shareholders